Defining optimal initial therapy for primary CNS lymphoma.
Schiff, David
Defining optimal initial therapy for primary CNS lymphoma. [electronic resource] - The Lancet. Haematology 05 2016 - e206-7 p. digital
Publication Type: Journal Article; Comment
2352-3026
10.1016/S2352-3026(16)30021-7 doi
Central Nervous System Neoplasms
Cytarabine
Humans
Methotrexate
Rituximab
Thiotepa
Defining optimal initial therapy for primary CNS lymphoma. [electronic resource] - The Lancet. Haematology 05 2016 - e206-7 p. digital
Publication Type: Journal Article; Comment
2352-3026
10.1016/S2352-3026(16)30021-7 doi
Central Nervous System Neoplasms
Cytarabine
Humans
Methotrexate
Rituximab
Thiotepa